337 related articles for article (PubMed ID: 28465778)
1. The Challenge of Managing Psoriasis: Unmet Medical Needs and Stakeholder Perspectives.
Feldman SR; Goffe B; Rice G; Mitchell M; Kaur M; Robertson D; Sierka D; Bourret JA; Evans TS; Gottlieb A
Am Health Drug Benefits; 2016 Dec; 9(9):504-513. PubMed ID: 28465778
[TBL] [Abstract][Full Text] [Related]
2. Managed care aspects of psoriasis and psoriatic arthritis.
Evans C
Am J Manag Care; 2016 Jun; 22(8 Suppl):s238-43. PubMed ID: 27356195
[TBL] [Abstract][Full Text] [Related]
3. Contemporary management of moderate to severe plaque psoriasis.
Wu JJ
Am J Manag Care; 2017 Dec; 23(21 Suppl):S403-S416. PubMed ID: 29297664
[TBL] [Abstract][Full Text] [Related]
4. Treating patients with moderate-to-severe psoriasis vulgaris.
Kessler TR
JAAPA; 2022 Mar; 35(3):28-35. PubMed ID: 35120363
[TBL] [Abstract][Full Text] [Related]
5. Biologics for the primary care physician: Review and treatment of psoriasis.
Schadler ED; Ortel B; Mehlis SL
Dis Mon; 2019 Mar; 65(3):51-90. PubMed ID: 30037762
[TBL] [Abstract][Full Text] [Related]
6. Practical management of psoriasis in the elderly: epidemiology, clinical aspects, quality of life, patient education and treatment options.
Yosipovitch G; Tang MB
Drugs Aging; 2002; 19(11):847-63. PubMed ID: 12428994
[TBL] [Abstract][Full Text] [Related]
7. Humanistic and Economic Impact of Moderate to Severe Plaque Psoriasis in Brazil.
Lopes N; Dias LLS; Azulay-Abulafia L; Oyafuso LKM; Suarez MV; Fabricio L; Kobata CM; Cestari T; Gontijo B; Sabbag CY; Antonio JR; Romiti R; Pertel PC
Adv Ther; 2019 Oct; 36(10):2849-2865. PubMed ID: 31432463
[TBL] [Abstract][Full Text] [Related]
8. Anti-TNF agents for the treatment of psoriasis.
Kircik LH; Del Rosso JQ
J Drugs Dermatol; 2009 Jun; 8(6):546-59. PubMed ID: 19537380
[TBL] [Abstract][Full Text] [Related]
9. Advances in Psoriasis.
Smith J; Cline A; Feldman SR
South Med J; 2017 Jan; 110(1):65-75. PubMed ID: 28052180
[TBL] [Abstract][Full Text] [Related]
10. Current and Under Development Treatment Modalities of Psoriasis: A Review.
Albaghdadi A
Endocr Metab Immune Disord Drug Targets; 2017; 17(3):189-199. PubMed ID: 28782467
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of moderate-to-severe psoriasis treatment.
Miller DW; Feldman SR
Expert Opin Pharmacother; 2006 Feb; 7(2):157-67. PubMed ID: 16433581
[TBL] [Abstract][Full Text] [Related]
12. Increasing Access to Effective Systemic Treatments in Patients with Moderate-to-Severe Psoriasis: Narrative Review.
Girolomoni G; Savage L; Gisondi P; Svensson Å; Mahé E; Augustin M; Puig L
Dermatol Ther (Heidelb); 2023 Oct; 13(10):2171-2185. PubMed ID: 37710078
[TBL] [Abstract][Full Text] [Related]
13. Physician perspectives in the management of psoriasis and psoriatic arthritis: results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis survey.
van de Kerkhof PC; Reich K; Kavanaugh A; Bachelez H; Barker J; Girolomoni G; Langley RG; Paul CF; Puig L; Lebwohl MG
J Eur Acad Dermatol Venereol; 2015 Oct; 29(10):2002-10. PubMed ID: 25885420
[TBL] [Abstract][Full Text] [Related]
14. Systemic treatment for moderate to severe psoriasis: estimates of failure rates and direct medical costs in a north-eastern US managed care plan.
Feldman SR; Evans C; Russell MW
J Dermatolog Treat; 2005 Feb; 16(1):37-42. PubMed ID: 15897166
[TBL] [Abstract][Full Text] [Related]
15. A retrospective cohort study of the impact of biologic therapy initiation on medical resource use and costs in patients with moderate to severe psoriasis.
Fonia A; Jackson K; Lereun C; Grant DM; Barker JN; Smith CH
Br J Dermatol; 2010 Oct; 163(4):807-16. PubMed ID: 20662837
[TBL] [Abstract][Full Text] [Related]
16. Providing Guidance for Patients With Moderate-to-Severe Psoriasis Who Are Candidates for Biologic Therapy: Role of the Nurse Practitioner and Physician Assistant.
Aldredge LM; Young MS
J Dermatol Nurses Assoc; 2016 Jan; 8(1):14-26. PubMed ID: 27004085
[TBL] [Abstract][Full Text] [Related]
17. Biologic Therapy Utilization in Patients With Moderate to Severe Psoriasis and Psoriatic Arthritis: An Observational Summary of Biologic Therapy Use in a Clinical Setting.
Gulliver WP; Randell S; Gulliver S; Gregory V; Nagle S; Chambenoit O
J Cutan Med Surg; 2018; 22(6):567-576. PubMed ID: 29952225
[TBL] [Abstract][Full Text] [Related]
18. Rationale, objectives and design of PURE, a prospective registry of patients with moderate to severe chronic plaque psoriasis in Canada and Latin America.
Papp KA; Gooderham M; Beecker J; Lynde CW; Delorme I; Dei-Cas I; Albrecht L; Rampakakis E; Sampalis JS; Vieira A; Hussein S; Chambenoit O; Rihakova L
BMC Dermatol; 2019 Jun; 19(1):9. PubMed ID: 31226985
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
